# US 2026/0217748 A1 · Ibogaine and noribogaine prodrugs and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0217748 A1
- Document ID: US20260217748A1
- Status: Published application
- Kind: A1
- Application number: 19/143,299
- Filed: 2023-12-28
- Published: 2026-07-30
- Earliest claimed: 2022-12-29
- Applicants: Atai Therapeutics, Inc.
- Inventors: Tanweer KHAN
- Web page: https://patentgrep.com/patent/US20260217748A1

## CPC

- C07F 9/6561: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61P 25/30: for treating abuse or dependence
- C07D 471/18: Bridged systems
- C07D 471/22: in which the condensed systems contains four or more hetero rings
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Provided herein are compounds of Formula (I), Formula (II), pharmaceutically acceptable salts thereof, and compositions thereof, wherein R, R1, R2, and M are defined herein. The disclosed compounds are useful for treating various conditions, including alcoholism, substance abuse disorder, and opioid use disorder.

## Claims

### Claim 1

A compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
M is hydrogen, C1-C8 alkyl, —CR1R2—O—C1-C5 alkyl, or
R is hydrogen, C1-C8 alkyl, or cycloalkyl;
R1 and R2 are independently hydrogen, C1-C8 alkyl, or cycloalkyl, or R1 and R2 together with the atoms to which they are attached form a C3-C8 cycloalkyl; and
R3 and R4 are independently hydrogen, C1-C8 alkyl, cycloalkyl, alkylene-cycloalkyl, aryl, or R3 and R4 together with the atoms to which they are attached form a heterocycle,
wherein when R is methyl and R1 and R2 are hydrogen, M is not hydrogen.

### Claim 2 (depends on 1)

The compound of claim 1, wherein M is C1-C8 alkyl.

### Claim 3 (depends on 1)

The compound of claim 1, wherein M is C1-C3 alkyl.

### Claim 4 (depends on 1)

The compound of claim 1, wherein M is

### Claim 5 (depends on 1)

The compound of claim 1, wherein M is —CR1R2—O—C1-C8 alkyl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein M is —CH2—O—CH3.

### Claim 7 (depends on 1)

The compound of claim 1, wherein M is —CH(CH3)—O—CH3.

### Claim 8 (depends on 4)

The compound of claim 4, wherein R3 and R4 are independently C1-C8 alkyl.

### Claim 9 (depends on 4)

The compound of claim 4, wherein R3 and R4 are independently C1-C3 alkyl.

### Claim 10 (depends on 4)

The compound of claim 4, wherein R3 and R4 together with the atoms to which they are attached form a 5- to 8-membered heterocycle.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein R1 and R2 are hydrogen.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein R1 is C1-C8 alkyl and R2 is hydrogen.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein R1 is C1-C3 alkyl and R2 is hydrogen.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein at least one of R1 and R2 is a substituted C1-C8 alkyl.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein R is hydrogen.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein R is C1-C5 alkyl.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein R is methyl.

### Claim 18 (depends on 1)

The compound of claim 1, having the formula:
or a pharmaceutically acceptable salt thereof.

### Claim 19

A compound of Formula (II):
or a pharmaceutically acceptable salt thereof, wherein:
M is hydrogen, C1-C8 alkyl or
R is hydrogen, C1-C8alkyl, or cycloalkyl;
R1 and R2 are independently hydrogen, C1-C8 alkyl, or cycloalkyl, or R1 and R2 together with the atoms to which they are attached form a C3-C8 carbocycle; and
R3 and R4 are independently hydrogen, C1-C8 alkyl, cycloalkyl, alkylene-cycloalkyl, aryl, or R3 and R4 together with the atoms to which they are attached form a heterocycle.

### Claim 20 (depends on 19)

The compound of claim 19, wherein M is C1-C8 alkyl.

### Claim 21 (depends on 19)

The compound of claim 19, wherein M is C1-C3 alkyl.

### Claim 22 (depends on 19)

The compound of any claim 19, wherein M is

### Claim 23 (depends on 22)

The compound of claim 22, wherein R3 and R4 are independently C1-C8 alkyl.

### Claim 24 (depends on 22)

The compound of claim 22, wherein R3 and R4 are independently C1-C3 alkyl.

### Claim 25 (depends on 22)

The compound of claim 22, wherein R3 and R4 together with the atoms to which they are attached form a 5- to 8-membered heterocycle.

### Claim 26 (depends on 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 19-25, wherein R1 and R2 are hydrogen.

### Claim 27 (depends on 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 19-25, wherein R1 is C1-C8 alkyl and R2 is hydrogen.

### Claim 28 (depends on 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 19-25, wherein R1 is C1-C3 alkyl and R2 is hydrogen.

### Claim 29 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The compound of any one of claims 19-28, wherein R is hydrogen.

### Claim 30 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The compound of any one of claims 19-28, wherein R is C1-C8 alkyl.

### Claim 31 (depends on 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The compound of any one of claims 19-28, wherein R is methyl.

### Claim 32 (depends on 19)

The compound of claim 19, having the formula:
or a pharmaceutically acceptable salt thereof.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

A pharmaceutical composition, comprising a compound of any one of claims 1-32 and a pharmaceutically acceptable excipient.
